Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NON-IV neoadjuvant peritumoral immunotherapy in vulvar cancer
NL-OMON60561Phase 1Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Feb 2026
- Countries
- 1
01
Overview
Phase 1, single-arm trial in Vulval carcinoma, sponsored by Amsterdam University Medical Center. Started Feb 2026; status: recruiting.
02
Conditions
Vulval carcinoma
Beyond the preview
Go deeper on NL-OMON60561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60561.